Full Schedule

On Demand

IDWeek Mentorship Program Happy Hour

On Demand

IDWeek Mentorship Program Luncheon

On Demand

IDea Incubator

On Demand

IDSA & HIVMA Business Meeting

On Demand

O-01 - Addressing MDRO colonization and infection

On Demand

1 - The Relationship Between Chlorhexidine Skin Concentration and Multidrug-Resistant Organism (MDRO) Colonization in ICU Patients

N5. Health Care-Associated Infections: Disinfection/Sterilization & Environmental Infection Prevention

On Demand

2 - Space Time Trends of Community Onset Staphylococcus aureus Infections in Children Living in Southeastern United States 2002-2016

N9. Health Care-Associated Infections: Gram-positives (MRSA, MSSA, VRE)

On Demand

3 - Stopping Hospital Infections with Environmental Services (SHINE): A Cluster-Randomized Trial of Intensive Monitoring Methods for Terminal Room Cleaning on Rates of Multidrug-Resistant Organisms (MDROs) in the Intensive Care Unit (ICU)

N5. Health Care-Associated Infections: Disinfection/Sterilization & Environmental Infection Prevention

On Demand

4 - 137 Hospital Cluster-Randomized Trial of Mupirocin-Chlorhexidine vs Iodophor-Chlorhexidine for Universal Decolonization in Intensive Care Units (ICUs) (Mupirocin Iodophor Swap Out Trial)

N9. Health Care-Associated Infections: Gram-positives (MRSA, MSSA, VRE)

On Demand

5 - The PROTECT Trial: A Cluster Randomized Clinical Trial of Universal Decolonization with Chlorhexidine and Nasal Povidone Iodine Versus Standard of Care for Prevention of Infections and Hospital Readmissions among Nursing Home Residents

N5. Health Care-Associated Infections: Disinfection/Sterilization & Environmental Infection Prevention

On Demand

O-02 - Blood Stream Infections and Sepsis

On Demand

6 - Staphylococcus aureus in a Single Blood Culture Bottle Should We be Concerned?

C7. Bacteremia

On Demand

7 - Clinical outcomes and epidemiological characteristics of bacteremia in the older population of Japan

C7. Bacteremia

On Demand

8 - Sepsis-Associated Acute Kidney Injury and Acute Kidney Disease: A 15-Year Cohort Study of 4,226 Adult Sepsis Inpatient Survivors at a Tertiary Medical Center in Taiwan

C7. Bacteremia

On Demand

9 - The Skip Phenomenon in Staphylococcus aureus Bacteremia: Clinical Associations

C7. Bacteremia

On Demand

10 - spanImpact of Infectious Disease Consultation and Theoretical Management Bundle in Patients with Candidemia/span

C7. Bacteremia

On Demand

O-03 - Building Your Toolkit for HAI Surveillance and Stewardship

On Demand

11 - Electronic Surveillance Criteria for Non-Ventilator HAP Empiric testing and Chart Review at Veterans Affairs Facilities

N2. Health Care-Associated Infections: Surveillance

On Demand

12 - Development of Provider-Specific Antibiotic Prescribing Feedback for Inpatient Antibiotic Stewardship Programs in Veterans Affairs (VA) Facilities (ASP)

S1. Antimicrobial Stewardship program development and implementation

On Demand

13 - INSPIRE-ASP Pneumonia Trial: A 59 Hospital Cluster Randomized Evaluation of INtelligent Stewardship Prompts to Improve Real-time Empiric Antibiotic Selection versus Routine Antibiotic Selection Practices for Patients with Pneumonia

S1. Antimicrobial Stewardship program development and implementation

On Demand

14 - Effects of an Opt-Out Protocol for Antibiotic De-escalation among Selected Patients with Suspected Sepsis: The DETOURS Trial

S2. Antimicrobial Stewardship outcomes assessment (clinical and economic)

On Demand

O-04 - Challenges in C. difficile

On Demand

15 - Real-World Changes in Clostridioides difficile infection (CDI) Treatment Utilization and Clinical Outcomes Associated with Updated 2017 IDSA Guidelines among Medicare Beneficiaries in the U.S.

N8. Health Care-Associated Infections: C. difficile

On Demand

16 - Attributable Mortality, Healthcare Costs and Out-of-Pocket Costs of Clostridioides difficile Infection in US Medicare Advantage Enrollees

N8. Health Care-Associated Infections: C. difficile

On Demand

17 - Comparative Assessment of a Machine Learning Model and Rectal Swab Surveillance to Predict Hospital Onset Clostridioides difficile

N8. Health Care-Associated Infections: C. difficile

On Demand

18 - Global Surveillance of Clostridioides difficile Demonstrates High Prevalence in Non-Healthcare Settings

N8. Health Care-Associated Infections: C. difficile

On Demand

19 - The Impact of Investigational Purified Microbiome Therapeutic SER-109 on Health-Related Quality of Life (HRQoL) of Patients with Recurrent Clostridioides difficile Infection (rCDI) in ECOSPOR III, a Placebo-Controlled Clinical Trial

N8. Health Care-Associated Infections: C. difficile

On Demand

O-05 - Clinical Quandries in Viral Infections in ICH

On Demand

20 - Risk Factors for Breakthrough Cytomegalovirus (CMV) Infection and De Novo Resistance in Hematopoietic Cell Transplantation (HCT) Recipients Receiving Letermovir Prophylaxis

T3. Studies of the epidemiology of infections in transplant patients and patients with impaired immunity due to underlying disease or immunosuppressive drugs

On Demand

21 - Efficacy and Safety of Maribavir as a Rescue Treatment for Investigator Assigned Therapy in Transplant Recipients With Refractory or Resistant Cytomegalovirus Infections in the SOLSTICE Study: Phase 3 Trial Results

V1. Studies of the epidemiology of viral infections

On Demand

22 - International Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19 Impact of Risk Factors and Treatment Modalities on Outcome

Z9. COVID-19 Special populations (e.g. pregnant women, children, immunocompromised, etc)

On Demand

23 - Development and Validation of a Risk Score for Post-transplant Lymphoproliferative Disordersamong Solid Organ Transplant Recipients

T3. Studies of the epidemiology of infections in transplant patients and patients with impaired immunity due to underlying disease or immunosuppressive drugs

On Demand

24 - Longitudinal Assessment of Immune Responses to COVID-19 Vaccines in Solid Organ Transplant Recipients

Z11. COVID-19 Vaccines

On Demand

25 - Immunogenicity and Reactogenicity of COVID-19 mRNA Vaccines in Allogeneic Stem Cell Transplant Recipients

Z9. COVID-19 Special populations (e.g. pregnant women, children, immunocompromised, etc)

On Demand

O-06 - COVID-19 Complications, Co-infections and Clinical Outcomes 1

On Demand

26 - Risk of Post–COVID-19 Dyspnea and Interstitial Lung Disease (ILD) in a Real-World Cohort of Patients Hospitalized with COVID-19 in the United States

Z5. COVID-19 Complications, co-infections, and clinical outcomes

On Demand

27 - Co-infections and antimicrobial use in patients hospitalized with COVID-19

Z5. COVID-19 Complications, co-infections, and clinical outcomes

On Demand

28 - Utilizing the Charleston Comorbidity Index as an Independent Predictor for Outcomes in SARS-Cov-2 Positive Patients

Z5. COVID-19 Complications, co-infections, and clinical outcomes

On Demand

29 - Sustained Recovery in Patients Admitted to Hospital With COVID-19

Z5. COVID-19 Complications, co-infections, and clinical outcomes

On Demand

30 - SARS-CoV2 Reinfections in a University Teaching Hospital

Z5. COVID-19 Complications, co-infections, and clinical outcomes

On Demand

31 - Development a Novel Score (SAD-60) for Predicting Mortality in Hospitalised Patients with COVID-19 Pneumonia: A Multicenter Retrospective Study of 1013 Patients

Z5. COVID-19 Complications, co-infections, and clinical outcomes

On Demand

O-07 - COVID-19 Complications, Co-infections and Clinical Outcomes 2

On Demand

32 - Host Immune-Protein Signature Combining TRAIL, IP-10 and CRP for Early and Accurate Prediction of Severe COVID-19 Outcome

Z5. COVID-19 Complications, co-infections, and clinical outcomes

On Demand

33 - Evaluation of Rural-Urban Differences in Hospitalization and Mortality Rates for US COVID-19 Patients in the United States

Z7. COVID-19 Research

On Demand

34 - Long-term clinical outcomes following SARS-CoV-2 infection include persistent symptoms and cardiovascular disease beyond 3 months post-infection

Z5. COVID-19 Complications, co-infections, and clinical outcomes

On Demand

35 - Health-related quality of life in COVID-19 survivors after 12 months, a prospective cohort study.

Z7. COVID-19 Research

On Demand

36 - Clinical Features of and Risk Factors for 30-day Readmission after an Initial Hospitalization with COVID-19

Z7. COVID-19 Research

On Demand

37 - Allogeneic, Off-the-Shelf, SARS-CoV-2-specific T Cells Demonstrate Reactivity Against Emerging Variant Strains

Z7. COVID-19 Research

On Demand

O-08 - COVID-19 Treatment & Diagnostics

On Demand

38 - Remdesivir Treatment in Patients Hospitalized with COVID-19: A Comparative Analysis of In-Hospital All-Cause Mortality

Z4. COVID-19 Treatment

On Demand

39 - Anti-Spike Monoclonal Antibody Therapy for Kidney Transplant Recipients with COVID-19

Z4. COVID-19 Treatment

On Demand

40 - Lenzilumab Efficacy and Safety in Newly Hospitalized COVID-19 Subjects: Results From a Phase 3 Randomized Double-Blind Placebo-Controlled Trial

Z4. COVID-19 Treatment

On Demand

41 - Assessing Past vs Present COVID-19 Infection: A Survey of Criteria for Discontinuing Precautions in Asymptomatic Patients

Z2. COVID-19 Infection prevention

On Demand

O-09 - COVID-19 in Healthcare Settings

On Demand

42 - Outbreak of SARS-CoV-2 in Hospitalized Hemodialysis Patients an Epidemiologic and Genomic Investigation

Z1. COVID-19 Epidemiology and screening

On Demand

43 - SARS-CoV-2 Cycle threshold (Ct) values predict future COVID-19 cases

Z1. COVID-19 Epidemiology and screening

On Demand

44 - Impact of Nursing Home (NH) Universal Decolonization and COVID Prevention Training on COVID-19 Burden During the 2020-2021 Winter Surge in Orange County (OC), California (CA)

Z2. COVID-19 Infection prevention

On Demand

O-10 - Disparities in COVID Access to Care and Diagnostic Testing

On Demand

45 - COVID-19 Vulnerability and Data Reporting in Africa:Reflections from Cameroon

Z8. COVID-19 Global response/response in low resource settings

On Demand

46 - Racial and Ethnic Disparities in COVID-19 Incidence among Persons with HIV in a Multisite-Cohort

Z12. COVID-19 Social determinants of health

On Demand

47 - Impact of COVID-19 Pandemic on an Emergency Department Opt-out HIV Screening Program:An Interrupted Time Series Analysis

H1. HIV: Epidemiology and screening

On Demand

48 - Time Between Viral Loads for Suppressed and Non-Suppressed People with HIV During the COVID-19 Pandemic Compared to Pre-Pandemic

Z10. COVID-19 Impact of social distancing/mitigation measures

On Demand

49 - Effects of Maternal SARS-CoV-2 Infection on Neonatal Discharge Planning and Care: Exacerbation of Racial and Ethnic Healthcare Disparities

Z12. COVID-19 Social determinants of health

On Demand

O-11 - Disparities in HIV PrEP and Continum of HIV Care

On Demand

50 - Pilot Study on Offering HIV Pre-Exposure Prophylaxis (PrEP) to People Who Inject Drugs (PWID) in the Inpatient Setting

H2. HIV: Prevention

On Demand

51 - Patient Reported Outcomes Collection: A Mixed Methods Study at an urban HIV Clinic associated with a Historically Black Medical College in the Southern United States

H6. HIV: Social determinants of health

On Demand

52 - PrEP Adherence and Discontinuation at a Pharmacy-Supported PrEP Program in Atlanta, GA

H2. HIV: Prevention

On Demand

53 - Sex and Race Disparities in Premature Mortality among People with HIV: A 21-Year Observational Cohort Study

H1. HIV: Epidemiology and screening

On Demand

54 - Self-Perception of Risk for HIV Acquisition and Calculated Risk for HIV Acquisition Among Active Duty Air Force Members with Newly Diagnosed HIV Infection

H1. HIV: Epidemiology and screening

On Demand

O-12 - Endocarditis

On Demand

55 - Infective Endocarditis After Surgical or Transcatheter Aortic Valve Replacement

C8. Endocarditis

On Demand

56 - Long-Term Cardiovascular Outcomes After Drug-Related vs Non-Drug-Related Infective Endocarditis

C8. Endocarditis

On Demand

57 - Evaluation of the 2019 European Heart Rhythm Association International Consensus Document in Patients with Cardiovascular Implantable Electronic Devices Who Develop Staphylococcus aureus Bacteremia

C8. Endocarditis

On Demand

58 - Cost-Effectiveness of Emerging Antibiotic Strategies for the Treatment of Drug-Use Associated Infective Endocarditis

C8. Endocarditis

On Demand

O-13 - GNB bacteremia

On Demand

59 - Risk Factors for Recurrent Gram-Negative Bacterial Bloodstream Infections

C7. Bacteremia

On Demand

60 - Creation and Comparison of a Machine Learning Decision Tree and Traditional Risk Score to Predict Ceftriaxone Resistance in Cancer Patients with E. coli Bacteremia

C7. Bacteremia

On Demand

61 - Short- versus prolonged-courses of antimicrobial therapy for patients with uncomplicated Pseudomonas aeruginosa bloodstream infection

C7. Bacteremia

On Demand

62 - Follow-Up Blood Culture Practices for Gram-Negative Bloodstream Infections in Immunocompromised Hosts at a Large Academic Medical Center

C7. Bacteremia

On Demand

O-14 - Have we peaked? Updates in PK/PD

On Demand

63 - PK-RNN-V: A Deep Learning Model for Vancomycin Therapeutic Drug Monitoring using Electronic Health Record Data

A2. PK/PD studies

On Demand

64 - Novel Biomarkers Improve Estimation of Vancomycin Clearance in Critically Ill Children

A2. PK/PD studies

On Demand

65 - In Vivo Efficacy of Human Simulated Minocycline (MIN) against Stenotrophomonas maltophilia (STM)

A2. PK/PD studies

On Demand

66 - Utilizing ceftazidime/avibactam therapeutic drug monitoring in the treatment of neurosurgical meningitis caused by Difficult-to-treat resistant (DTR)-Pseudomonas aeruginosa and KPC-producing Enterobacterales

A2. PK/PD studies

On Demand

O-15 - HIV Co-infections and Co-morbidities

On Demand

68 - Comparison of Cardiovascular Risk Assessment Calculators in the US Military HIV Natural History Study

H5. HIV: Complications and co-infections

On Demand

69 - Incidence of metabolic complications among treatment-naïve adults living with HIV-1 randomized to B/F/TAF, DTG/ABC/3TC or DTG+F/TAF after 144 Weeks

H4. HIV: Treatment

On Demand

70 - Changes in Invasive Pneumococcal Disease among Adults Living with HIV Following Introduction of 13-Valent Pneumococcal Conjugate Vaccine, 2008–2018

H5. HIV: Complications and co-infections

On Demand

71 - Increasing Trends in Multimorbidity and Polypharmacy Over a 5-Year Period in People Living with HIV in the United States

H5. HIV: Complications and co-infections

On Demand

72 - Massive Weight Gain in People with HIV (PWH) Starting Initial Antiretroviral Therapy (ART): Risk Factors and Predictive Ability of Early Weight Gain

H5. HIV: Complications and co-infections

On Demand

O-16 - HIV Treatment

On Demand

73 - Interim Resistance Analysis of Long-Acting Lenacapavir in Treatment-Naïve People with HIV at 28 Weeks

H4. HIV: Treatment

On Demand

74 - Maternal Dolutegravir (DTG) Use During Pregnancy and Birth Outcomes: The Antiretroviral Pregnancy Registry (APR)

H4. HIV: Treatment

On Demand

75 - High Rates of Virologic Suppression with DTG/3TC in Newly Diagnosed Adults with HIV-1 Infection and Baseline Viral Load >500,000 c/mL: 48-Week Subgroup Analysis of the STAT Study

H4. HIV: Treatment

On Demand

76 - Effects of the “Undetectable = Untransmittable” (“U=U”) Educational Campaign on Treatment Outcomes and Perceptions among People Living with HIV in North American Countries

G. Global Health (e.g., travel medicine, tropical medicine and parasitology, endemic/epidemic diseases of resource-challenged areas, social determinants of health)

On Demand

77 - Risk of Virologic Failure Among Treatment-experienced Suppressed People with HIV (PWH) Treated with Single-Tablet 2-Drug (2DR) vs 3-Drug (3DR) Regimens

H4. HIV: Treatment

On Demand

O-17 - Hot topics in pediatric viral and fungal infections

On Demand

78 - Non-Invasive Prediction of Invasive Fungal Infection by Plasma-Based Microbial Cell-Free DNA Next-Generation Sequencing (mcfDNA NGS) in Pediatric Patients with Relapsed or Refractory Leukemia

P2. Pediatric Fungal studies (natural history and therapeutic)

On Demand

79 - Children with COVID-19 Demonstrate Distinct Serum Cytokines Profiles According to Clinical Presentations

P3. Pediatric Viral studies (natural history and therapeutic)

On Demand

80 - Heme Oxygenase-1 Gene promoter and associations with inflammation and subclinical vascular disease in Ugandan adolescents with and without HIV

P6. Pediatric HIV

On Demand

81 - SARS-CoV-2 RNAemia and Disease Severity in Pediatric Coronavirus Disease 2019 (COVID-19)

P3. Pediatric Viral studies (natural history and therapeutic)

On Demand

82 - Blood Gene Expression Profiles in Neonates with Herpes Simplex Virus (HSV) Infection

P7. Pediatric Maternal-child infections

On Demand

O-18 - Improving Medical Education in Infectious Disease

On Demand

83 - ID Coaches Contribute to a Highly Effective Learning Experience for Third-Year Medical Students Rotating on the Infectious Diseases Consult Service

E. Infectious Diseases Medical Education (scholarly work directed at enhancing infectious diseases education of trainees and/or health professionals, social determinants of health)

On Demand

84 - Paying for Parenthood: Misinterpretation of ABIM Leave Policies May Lead to Unnecessary Extension of ID Fellowships

E. Infectious Diseases Medical Education (scholarly work directed at enhancing infectious diseases education of trainees and/or health professionals, social determinants of health)

On Demand

85 - A Virtual Platform for Mentoring Clinician Educators at IDWeek is as Effective as In-Person

E. Infectious Diseases Medical Education (scholarly work directed at enhancing infectious diseases education of trainees and/or health professionals, social determinants of health)

On Demand

86 - Making the APPropriate Choice: Utilization of a Smartphone Application to Optimize Antimicrobial Decisions Among Internal Medicine Trainees

E. Infectious Diseases Medical Education (scholarly work directed at enhancing infectious diseases education of trainees and/or health professionals, social determinants of health)

On Demand

87 - Infectious Disease Diversity, Equity, and Antiracism (ID2EA): A Dedicated Curriculum for Infectious Disease Professionals

Y5. Structural equity (Inclusion, Diversity, Access and Equity)

On Demand

O-19 - Infection control and stewardship challenges in diverse settings

On Demand

88 - Review of nursing home antibiotic stewardship citation deficiencies to identify opportunities to improve antibiotic stewardship implementation, 2018-2019

S4. Antibiotic Stewardship: Special Populations

On Demand

89 - Positive Blood Culture Trends and Variability among U.S. Hospitals, 2012-2017

S3. Antibiotic Stewardship: Diagnostics/Diagnostic Stewardship

On Demand

90 - Impact of Infection Control Assessment and Response (ICAR) Visit on Candida auris Colonization Rates at Seven Long Term Acute Care Hospitals (LTACH) in Los Angeles County

N2. Health Care-Associated Infections: Surveillance

On Demand

91 - Gaps and Opportunities in Antimicrobial Stewardship Programs in Asia: A Survey of 10 Countries

S1. Antimicrobial Stewardship program development and implementation

On Demand

O-20 - Infection risks from invasive procedures

On Demand

92 - Characteristics and Outcomes of Deep Brain Stimulation Device Related Infections: Experience from Quaternary Centers

N4. Health Care-Associated Infections: Device-Associated (CLABSI, CAUTI, VAP)

On Demand

93 - Early Recognition and Response to Increases in Surgical Site Infections (SSI) using Optimized Statistical Process Control (SPC) Charts – the Early 2RIS Trial: A Multicenter Stepped Wedge Cluster Randomized Controlled Trial (RCT)

N7. Health Care-Associated Infections: Surgical Site Infections

On Demand

94 - Infectious Complications of Left Ventricular Assist Devices

N7. Health Care-Associated Infections: Surgical Site Infections

On Demand

95 - Impact of Penetrating Trauma on Surgical Site Infection Standardized Infection Ratio (SIR) for Colon Procedures

N7. Health Care-Associated Infections: Surgical Site Infections

On Demand

O-21 - Innovations and Advancements in Vaccines

On Demand

96 - Relative Vaccine Effectiveness Against Influenza-Related and Any Respiratory-Related Hospital Encounter During the 2019/20 High Influenza Activity Period: A Comprehensive Real-World Analysis to Compare Quadrivalent Cell-based and Egg-based Influenza Vaccines

I4. New vaccines (formerly L3)

On Demand

97 - Tetravalent Dengue Vaccine (TAK-003) Development Program: A Bird’s Eye View

I4. New vaccines (formerly L3)

On Demand

98 - COVID-19 Vaccine Breakthrough Hospitalizations and Deaths in the Veterans Health Administration

Z11. COVID-19 Vaccines

On Demand

99 - Immune Responses to Influenza Vaccines in Children and Young Adults

I2. Pediatric Vaccines

On Demand

100 - Safety Analysis of Live-Attenuated Measles, Mumps, Rubella Vaccine Among Hematopoietic Cell Transplant Recipients Vaccinated Within Two Years of Transplant

I1. Adult Vaccines

On Demand

101 - PCV13 Pediatric Vaccination Disparity and Impact Due to COVID-19 Pandemic in the US

I2. Pediatric Vaccines

On Demand

O-22 - Neurologic Infections

On Demand

102 - A Retrospective Case Series of West Nile Neuroinvasive Disease in Two Tertiary Health Centers in Miami

C9. CNS Infection

On Demand

103 - An Association Between Abnormal CSF Analysis and Inpatient Mortality in Cryptococcal Meningitis, a Tertiary Care Center Experience

C9. CNS Infection

On Demand

104 - Plague Meningitis - A Systematic Review of Published Cases, Antimicrobial Treatment, and Outcomes

C9. CNS Infection

On Demand

105 - Impact of a Multiplex Polymerase Chain Reaction Panel on Duration of Empiric Antibiotic Therapy in Suspected Bacterial Meningitis

C9. CNS Infection

On Demand

106 - Risk Classification to Differentiate Autoimmune from Viral Encephalitis

C9. CNS Infection

On Demand

O-23 - New Developments in Antibiotic Efficacy

On Demand

107 - A Phase 3, Randomized, Double-Blind Study to Evaluate the Efficacy and Safety of Oteseconazole (VT-1161) Oral Capsules versus Fluconazole and Placebo in the Treatment of Acute Vulvovaginal Candidiasis Episodes in Subjects with Recurrent Vulvovaginal Candidiasis (ultraViolet)

C1. Clinical trials

On Demand

108 - Efficacy of Dalbavancin Compared to Standard of Care for the Treatment of Osteomyelitis: A Retrospective Study

C2. Bone and joint

On Demand

109 - Evaluating Predictive Value of Surgical Resected Proximal Bone Margins in Diabetic Foot Osteomyelitis with Clinical Outcomes at One Year

C2. Bone and joint

On Demand

110 - A Phase 3, Multicenter, Double-blind, Randomized Clinical Trial to Evaluate the Efficacy and Safety of Ceftolozane/Tazobactam Plus Metronidazole Versus Meropenem in Chinese Participants With Complicated Intra-abdominal Infections

C1. Clinical trials

On Demand

111 - Duration of Antibiotic Therapy after Debridement and Implant Retention in Patients with Periprosthetic Joint Infections

C2. Bone and joint

On Demand

O-24 - New Developments in Infectious Diseases Diagnostics

On Demand

112 - A Rapid Host-Protein Signature Based on TNF-related Apoptosis-Induced Ligand (TRAIL), Interferon Gamma Induced Protein-10 (IP-10) and C-Reactive Protein (CRP) Accurately Differentiates Between Bacterial and Viral Infection in Febrile Children: Apollo Sub-Study

D7. Other (e.g., host response biomarkers, molecular imaging, metabolomics/proteomics, etc.)

On Demand

113 - Reliability of Nasopharyngeal PCR for the Detection of Otopathogens in Children with Uncomplicated Acute Otitis Media

D1. Diagnostics: Bacteriology/mycobacteriology

On Demand

114 - Prospective Trial of Passive Diversion Device to Reduce Blood Culture Contamination

D6. New diagnostics (formerly L2)

On Demand

115 - The Utility of (1→3)-𝝱-D-glucan Assay in the Diagnosis of Severe Coccidioidomycosis Infections among Immunocompromised Hosts

D4. Mycology

On Demand

116 - Characterization of small colony variants from a patient with bloodstream infection of Candida glabrata

D4. Mycology

On Demand

117 - Trends in Four-class HIV Drug Resistance in Treatment-experienced Patients in the United States

D2. Virology

On Demand

118 - Machine Learning Approaches to Predicting Treatment Outcomes for Carbapenem-Resistant Enterobacterales in a Region with High Prevalence of Non-Carbapenemase Producers

D6. New diagnostics (formerly L2)

On Demand

O-25 - New Findings in Medical Mycology

On Demand

119 - A Humanized Antibody Targeting the CotH Invasins is Protective Against Murine Mucormycosis

A1. Novel Agents

On Demand

120 - An open-label comparative trial of SUBA-itraconazole (SUBA) versus conventional itraconazole (c-itra) for treatment of proven and probable endemic mycoses (MSG-15): a pharmacokinetic (PK) and adverse Event (AE) analysis

M1. Clinical studies of fungal infections

On Demand

121 - Mucormycosis and COVID-19 in the United States: a Real-World Evidence Analysis of Risk Factors and Survival Among Patients with Mucormycosis, with and without COVID-19 Preceding the Infection

Z5. COVID-19 Complications, co-infections, and clinical outcomes

On Demand

122 - Impact of Infectious Diseases Consultation in Patients with Candidemia at a Large Multi-site Healthcare System Providing Telemedicine Services

M1. Clinical studies of fungal infections

On Demand

123 - Oral Ibrexafungerp Outcomes by Fungal Disease in Patients from an Interim Analysis of a Phase 3 Open-label Study (FURI)

M1. Clinical studies of fungal infections

On Demand

124 - Establishment of a Post-Influenza Aspergillosis Model in Corticosteroid-Immunosuppressed Mice

M3. Studies of the pathogenesis of fungal infections

On Demand

O-26 - New Insights into Microbial Pathogenesis

On Demand

125 - Dynamic PET facilitated Pharmacokinetic Modeling and High-dose Rifampin Regimens for Staphylococcus aureus Orthopedic Implant Associated Infections: Bench to Bedside

B1. Studies of correlates of protection (or biomarkers) against microbial infection and disease in patients or experimental models

On Demand

126 - Magnitude and Dynamics of the T-Cell Response to SARS-CoV-2 Infection and Vaccination

B2. Studies of the immune response to microbial infection and disease in patients or experimental models

On Demand

127 - Development of a kinetic ELISA (kELISA) and Reactive B-cell Frequency (RBF) Assay to Detect Respiratory Syncytial Virus (RSV) Pre-Fusion F Protein-Specific Immune Responses in Infants

B2. Studies of the immune response to microbial infection and disease in patients or experimental models

On Demand

128 - Mutations that Inactivate the Tricarboxylic Acid Cycle in Staphylococcus aureus Arise During Persistent MRSA Bacteremia

B4. Studies of microbial factors that govern susceptibility to microbial infection and disease

On Demand

129 - Antimicrobial Resistance Genes were Reduced Following Administration of Investigational Microbiota-Based Live Biotherapeutic RBX2660 to Individuals with Recurrent Clostridioides difficile Infection

B4. Studies of microbial factors that govern susceptibility to microbial infection and disease

On Demand

O-27 - Novel Antimicrobial Agents

On Demand

130 - Design and Preclinical Characterization of SER-155, an Investigational Cultivated Microbiome Therapeutic to Restore Colonization Resistance and Prevent Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation

A1. Novel Agents

On Demand

131 - Antiviral NL-CVX1 efficiently blocks infection of SARS-CoV-2 viral variants of concern (VOC)

A1. Novel Agents

On Demand

132 - Evaluation Phage Cocktails in Combination with Ciprofloxacin Against Multidrug-Resistant Pseudomonas aeruginosa Overexpressing MexAB-OprM Efflux Systems

A1. Novel Agents

On Demand

133 - ARGONAUT-III: Susceptibility of Carbapenem-resistant Klebsiellae to Cefepime-Taniborbactam

A1. Novel Agents

On Demand

134 - KRP-A218, an Orally Active and Selective PI4KB Inhibitor with Broad-Spectrum Anti-Rhinovirus Activity, Has Potent Therapeutic Antiviral Activity in vivo

A1. Novel Agents

On Demand

O-28 - Practice Issues

On Demand

135 - Association Between Implementation of the Centers for Medicare & Medicaid Services Sepsis Performance Measure (SEP-1) and Outcomes in U.S. Hospitals

J. Clinical Practice Issues (e.g., billing, medical records & informatics, healthcare reform, home health/OPAT)

On Demand

136 - Impact of an OPAT Pharmacist on Guideline Adherence and Clinical Outcomes

J. Clinical Practice Issues (e.g., billing, medical records & informatics, healthcare reform, home health/OPAT)

On Demand

137 - Risk Factors of B-lactams Associated Cytopenias during Outpatient Parenteral Antimicrobial Therapy: Results from a Large National Sample

J. Clinical Practice Issues (e.g., billing, medical records & informatics, healthcare reform, home health/OPAT)

On Demand

138 - Tele-COVID Rounds and Tele-Stewardship Surveillance Reduces Antibiotic Use in COVID-19 Patients Admitted to 17 Small Community Hospitals

Z5. COVID-19 Complications, co-infections, and clinical outcomes

On Demand

139 - Social Support Decreases No-Show Rates Among Patients with Injection-Drug-Use-Related Infections and Opioid Use Disorder

J. Clinical Practice Issues (e.g., billing, medical records & informatics, healthcare reform, home health/OPAT)

On Demand

O-29 - Prescribing and Prophylaxis Predicaments

On Demand

140 - Antibiotic prophylaxis for upper gastrointestinal bleed in liver cirrhosis: less may be more

S4. Antibiotic Stewardship: Special Populations

On Demand

141 - Effectiveness of a Multipronged Approach to Improve Prophylactic Antibiotic Prescribing in Patients Undergoing Trans-Arterial Chemoembolization

N7. Health Care-Associated Infections: Surgical Site Infections

On Demand

142 - Impact of an Antimicrobial Stewardship Intervention on Antibiotic Prescribing in Patients with Obstetric Infection and Penicillin Allergy

S4. Antibiotic Stewardship: Special Populations

On Demand

143 - Use of First-Generation Cephalosporins in Patients with Serious Penicillin Allergies

S4. Antibiotic Stewardship: Special Populations

On Demand

O-30 - Research in COVID-19 Diagnostics

On Demand

144 - Clinical Validation and Performance of a T-cell Immunosequencing Assay to Identify Past SARS-CoV-2 Infection

Z6. COVID-19 Diagnostics

On Demand

145 - SARS-CoV-2 (COVID-19) Testing Experience within a Military Treatment Facility

Z6. COVID-19 Diagnostics

On Demand

146 - Intact Sense of Taste and Smell During COVID-19 Infection is Associated with Absence of of SARS-CoV-2 Spike Protein Antibody Responses within 3 Months of Symptomatic Illness

Z7. COVID-19 Research

On Demand

147 - Defining the optimal serial testing interval and features for identifying patients with early SARS-CoV-2 infection

Z6. COVID-19 Diagnostics

On Demand

148 - Single-amplicon, multiplex real-time RT-PCR with tiled probes to detect SARS-CoV-2 spike mutations associated with variants of concern

D2. Virology

On Demand

149 - Extraction-free RT-PCR to Detect SARS-CoV-2 Variants of Concern

Z6. COVID-19 Diagnostics

On Demand

O-31 - Respiratory Infections

On Demand

150 - Updated Clinical Guidelines for Treatment and Prophylaxis of Plague

C5. Respiratory infections - bacterial

On Demand

151 - Simplifying Empiric Antimicrobial Therapy Selection for Lower Respiratory Tract Infections in Intensive Care Unit Patients: Using Resistance Frequency to Guide Decision Making

C5. Respiratory infections - bacterial

On Demand

152 - Sharp decline in rates of community respiratory viral infections among NIH Clinical Center patients during the COVID-19 pandemic

C4. Respiratory infections - viral

On Demand

153 - Gone Are the Other Respiratory Viruses During COVID…but the Rhinovirus/Enterovirus “Cockroach” Persists!

C4. Respiratory infections - viral

On Demand

154 - Circulation of Rhinovirus/Enterovirus Respiratory Infections in Children During 2020-21 in the United States

C4. Respiratory infections - viral

On Demand

155 - In Vitro Evaluation of Delafloxacin Activity Against Contemporary US Isolates from Community-Acquired Pneumonia and Community-Acquired Lower Respiratory Tract Infections Results from the SENTRY Antimicrobial Surveillance Program (2014-2020)

C5. Respiratory infections - bacterial

On Demand

156 - Correlation Between WHO (World Health Organization) Case Definition of Severe Pneumonia and Lung POCUS (Point of Care Ultrasound) vs Chest X-ray (CXR) Findings to Diagnose Pediatric Community-Acquired Pneumonia (CAP) in Limited Resource Settings

C5. Respiratory infections - bacterial

On Demand

O-32 - Stewardship in Ambulatory Settings

On Demand

157 - Impact of Pharmacist-Generated Oral Antimicrobial Test Prescription on Discharge Medication Access and Outcome

S7. Antibiotic Stewardship: Social determinants of health

On Demand

158 - Impact of Fluoroquinolone Cascade Reporting of Urine Samples on Antibiotic Prescribing Rates in a Network of Urgent Care Clinics

S6. Antibiotic Stewardship: Trends in Antimicrobial Prescribing

On Demand

159 - Improving antibiotic use for sinusitis and upper respiratory tract infections: a virtual visit antibiotic stewardship initiative

S5. Antibiotic Stewardship: Non-Inpatient Settings

On Demand

160 - Evaluation of an Intervention to Promote Guideline-Concordant Durations of Antibiotic Therapy in Two Urgent Care Centers

S2. Antimicrobial Stewardship outcomes assessment (clinical and economic)

On Demand

161 - The Agency for Healthcare Research and Quality (AHRQ) Safety Program for Improving Antibiotic Use: Antibiotic Stewardship Intervention in 389 United States Ambulatory Practices during the COVID-19 Pandemic

S1. Antimicrobial Stewardship program development and implementation

On Demand

162 - The Impact of the COVID-19 Pandemic on Antibiotic Prescribing in Pediatric Primary Care

Z10. COVID-19 Impact of social distancing/mitigation measures

On Demand

O-33 - STIs and Enteric Infections

On Demand

163 - High Prevalence of Urogenital and Rectal Mycoplasma genitalium in U.S. MSM with a History of STIs in the Last Year

C10. Sexually transmitted infections

On Demand

164 - Antimicrobial Susceptibility of Urogenital and Extragenital Neisseria gonorrhoeae Isolates Among Men Who Have Sex with Men – SURRG and eGISP, 2018–2019

C10. Sexually transmitted infections

On Demand

165 - Emergence of Extensively Drug-Resistant Salmonella enterica Serotype Typhi InfectionsUnited States, 20082020

C6. Enteric infection

On Demand

166 - Congenital Syphilis in Minnesota, 2016-2020

C10. Sexually transmitted infections

On Demand

167 - Efficacy of Investigational Microbiota-Based Live Biotherapeutic RBX2660 in Individuals with Recurrent Clostridioides difficile Infection: Data from Five Prospective Clinical Studies

C6. Enteric infection

On Demand

168 - Testing, Diagnosis, and Incidence of Sexually Transmitted Infections Among People with Substance Use Disorders in the Veterans Health Administration, 2019

C10. Sexually transmitted infections

On Demand

O-34 - The interplay between COVID and other infections

On Demand

169 - The Resurgence of Candida auris in California during the Novel Coronavirus (COVID-19) Pandemic, May 2020-May 2021

O. Public Health (Issues pertaining to preparedness for and response to outbreaks including those linked to agents of bioterror, foodborne, waterborne, vector borne, zoonotic diseases, vaccine-preventable diseases and social determinants of health)

On Demand

170 - Reduction in Bloodborne Pathogen Splash Exposures After Implementation of Universal Masking and Eye Protection for COVID-19

N1. Health Care-Associated Infections: Occupational Infection Prevention

On Demand

171 - The Impact of COVID-19 on Healthcare-Associated Infections

N2. Health Care-Associated Infections: Surveillance

On Demand

172 - Impact of COVID-19 pandemic on healthcare-associated infections (HAIs) in a large network of hospitals

Z2. COVID-19 Infection prevention

On Demand

173 - Deciphering COVID-19-Associated Effects on Hospital MRSA Transmission and Social Networks

N9. Health Care-Associated Infections: Gram-positives (MRSA, MSSA, VRE)

On Demand

174 - Increase in Candida auris cases in New Jersey healthcare facilities during the COVID-19 pandemic 20172020

N13. Health Care-Associated Infections: Non-Bacterial (Fungal, Viral)

On Demand

O-35 - Trends in Gram-negative resistance

On Demand

175 - Antibiotic resistance in select Gram-negative bacteria over the past decade among hospitalized Veterans nationally

N10. Health Care-Associated Infections: Gram-negatives (MDR-GNR)

On Demand

176 - Antibiotic resistance patterns, seasonality, and correlation with the influenza season in the United States A multicenter evaluation reveals surprising association between influenza season and gram negative pathogens

V2. Studies of viral pathogenesis

On Demand

177 - Distinctive Features of Ertapenem Mono-Resistant Carbapenem-Resistant Enterobacterales in the United States A Cohort Study

N10. Health Care-Associated Infections: Gram-negatives (MDR-GNR)

On Demand

178 - Endemic Carbapenem Resistance Driven By Clonal and Horizontal Spread of blasubIMP-4/sub Across Diverse Enterobacterales Jumping Genes, Promiscuous Plasmids and Killer Clones

N10. Health Care-Associated Infections: Gram-negatives (MDR-GNR)

On Demand

179 - Identification and Whole Genome Sequencing Analysis of an Oxacillinase (OXA)-48-like-producing Acinetobacter baumannii Outbreak in California, January-May 2021

N11. Health Care-Associated Infections: Outbreaks

On Demand

180 - Alterations to the gut microbiomes and acquisition of bacteria resistance elements among US international travelers

G. Global Health (e.g., travel medicine, tropical medicine and parasitology, endemic/epidemic diseases of resource-challenged areas, social determinants of health)

On Demand

O-36 - Trends in pediatric bacterial disease

On Demand

181 - Potential Benefit of Masking and other COVID-19 Infection Prevention Measures on Late-Onset Infections in the NICU

P5. Pediatric Healthcare-associated infection epidemiology and prevention

On Demand

182 - Back to The Future: Increasing Penicillin Susceptibility among Methicillin-Susceptible Staphylococcus aureus Osteoarticular Infections in Children

P1. Pediatric Bacterial studies (natural history and therapuetic)

On Demand

183 - Decrease in Invasive Pneumococcal Disease in 7 United States Children’s Hospitals during the COVID-19 Pandemic

P1. Pediatric Bacterial studies (natural history and therapuetic)

On Demand

184 - Inducible Clindamycin Resistance Testing on Pediatric Streptococcus pneumoniae Isolates

P1. Pediatric Bacterial studies (natural history and therapuetic)

On Demand

185 - Trends in Clinical Presentation and Antibiotic Resistance of Viridans Group Streptococci Bloodstream Infections in Immunocompromised Children

T3. Studies of the epidemiology of infections in transplant patients and patients with impaired immunity due to underlying disease or immunosuppressive drugs

On Demand

O-37 - Updates in COVID epidemiology

On Demand

186 - Characteristics of COVID-19 Vaccine Breakthrough Cases in Minnesota, 2021

Z1. COVID-19 Epidemiology and screening

On Demand

187 - Characterizing household clustering of COVID-19 cases in Fulton County, Georgia, June 2020 April 2021

Z1. COVID-19 Epidemiology and screening

On Demand

188 - Visualizing the Impact of a Wedding Leading to COVID-19 Outbreaks in Healthcare Settings, Washington State, July – August 2020

N11. Health Care-Associated Infections: Outbreaks

On Demand

189 - Potential Tiger-to-Human Transmission of SARS-CoV-2 at a Tennessee Zoo: A One Health Approach to Outbreak Investigation

O. Public Health (Issues pertaining to preparedness for and response to outbreaks including those linked to agents of bioterror, foodborne, waterborne, vector borne, zoonotic diseases, vaccine-preventable diseases and social determinants of health)

On Demand

190 - Epidemiology of COVID-19 Breakthrough Infections in Dallas County, Texas, 2021

Z1. COVID-19 Epidemiology and screening

On Demand

O-38 - Updates in Mycobacteria

On Demand

191 - High-Dose Rifampin-containing Regimens for the Treatment of TB Meningitis

K. Tuberculosis and other Mycobacterial Infections

On Demand

192 - Tolerability outcomes of multi-drug antibiotic treatment for pulmonary nontuberculous mycobacterial disease due to Mycobacterium avium complex in U.S. Medicare beneficiaries with bronchiectasis

K. Tuberculosis and other Mycobacterial Infections

On Demand

193 - Impact of COVID-19 Pandemic on Pulmonary Tuberculosis Evaluations and Diagnosis at a Large Safety Net Hospital in Los Angeles, California

K. Tuberculosis and other Mycobacterial Infections

On Demand

O-39 - UTIs

On Demand

194 - Progression of an Uncomplicated Urinary Tract Infection Among Female Patients with Susceptible and Non-Susceptible Urine Isolates: Findings from an Integrated Delivery Network

C11. UTIs

On Demand

195 - Intravenous to Oral Antibiotics Versus Intravenous Antibiotics: A Step-Up or a Step-Down for Extended Spectrum Beta-Lactamase Producing Urinary Tract Infections?

C11. UTIs

On Demand

196 - Activity Impairment and Health-Related Quality of Life Associated with an Uncomplicated Urinary Tract Infection Among US Females

C11. UTIs

On Demand

197 - Healthcare Resource Utilization and Costs Associated with Inappropriate and Suboptimal Prescribing of Antibiotics for Uncomplicated Urinary Tract Infection in the United States

C11. UTIs

On Demand

198 - Comparison of Antibiotic Treatment Durations for Symptomatic Bacteriuria in Veterans with Spinal Cord Injuries or Disorders (SCI/D)

C11. UTIs

On Demand

O-40 - What's new in antimicrobial resistance

On Demand

199 - Polymorphisms in Key Regulatory Regions of the bla operon Correlate with the Cefazolin Inoculum Effect in Methicillin-Susceptible Staphylococcus aureus (MSSA)

A3. Resistance mechanisms

On Demand

200 - Antimicrobial Activity of Ceftazidime-Avibactam and Comparators against AmpC Hyperproducing Enterobacterales and P. aeruginosa Collected from United States (US) Medical Centers (2016-2020)

A4. Treatment of antimicrobial resistant infections

On Demand

201 - Frequency of Pseudomonas aeruginosa (PA) Discrete Inner Colonies and Comparison of Minimal Inhibitory Concentration (MIC) Values between Parent and Inner Colony Isolates Following Fosfomycin Disk Diffusion (DD) Testing

A4. Treatment of antimicrobial resistant infections

On Demand

202 - Comparative Activity of Ceftazidime-Avibactam, Imipenem-Relebactam and Meropenem-Vaborbactam Tested Against Carbapenem-Nonsusceptible Enterobacterales that are Carbapenemase-Negative

A4. Treatment of antimicrobial resistant infections

On Demand

203 - Activity of Cefepime in Combination with Taniborbactam (formerly VNRX-5133) Against Pseudomonas aeruginosa from a Global 2018-2020 Surveillance Collection

A4. Treatment of antimicrobial resistant infections

On Demand

PW01 - Vincent T. Andriole Board Review Course

On Demand

Bacterial Syndrome Pearls

On Demand

Fungal Infections

On Demand

HIV

On Demand

Infection Control/Prevention

On Demand

Key Concepts in ID Therapeutics

On Demand

Mycobacteria Including TB

On Demand

Nervous System Infections and Mimics

On Demand

Non-Infectious Causes of Elevated Temperature

On Demand

Parasitic Diseases

On Demand

Sexually Transmitted Infections

On Demand

Transplant Infections

On Demand

PW02 - Best Practices in Antimicrobial Stewardship Programs

On Demand

CLSI, EUCAST and USCAST: What does the antibiotic stewardship team need to know?

On Demand

How Can Nursing Fit on the Stewardship Team?

On Demand

Looking Forward: Implementing Diagnostic Stewardship in Antimicrobial Stewardship Efforts

On Demand

Outpatient Stewardship: Where Do I Even Start? - Adults

On Demand

Outpatient Stewardship: Where Do I Even Start? - Peds

On Demand

Update on National Stewardship Activities

On Demand

Welcome and Introduction

On Demand

Workshop Wrap Up and Close Out

On Demand

PW03 - Performance Improvement: Tools for the ID Practitioner

On Demand

PW04 - Research Training Programs and Grant Writing Strategies for ID Physician-Scientists

On Demand

Funding beyond NIH: Grantsmanship Guidance for Early Career ID-Scientists

On Demand

NIAID Research Career ("K") - The Perils of Review

On Demand

NIH Career Transition Grants

On Demand

NIH Peer Review

On Demand

Panel Discussion: Research Career Perspectives

On Demand

PW05 - Fellows' Day Workshop

On Demand

Careers in Antimicrobial Stewardship

On Demand

Careers in Clinical Practice

On Demand

Careers in Global Health

On Demand

Careers in Hospital Epidemiology and Infection Control

On Demand

Careers in Industry

On Demand

Careers in Medical Education

On Demand

Careers in Public Health

On Demand

Careers in Research

On Demand

Careers in Transplant/Oncology ID

On Demand

Case Presentation #1

Bacterial infections

On Demand

Case Presentation #2

Bacterial infections

On Demand

Case Presentation #3

HIV/AIDS

On Demand

Case Presentation #4

Viral infections (other than HIV)

On Demand

Case Presentation #5

Fungal infections

On Demand

Case Presentation #6

Mycobacterial infections

On Demand

Case Presentation #7

Bacterial infections

On Demand

Understanding Employment Agreements; How to Interview for a Job in ID

On Demand

PW06 - Pediatric Fellows' Day

On Demand

PW07 - Achieving Success and Scholarship as an Infectious Diseases Health Professions Educator Through Curriculum Development

On Demand

PW08 - Extending Antibiotic Stewardship into Outpatient Settings

On Demand

Antibiotic prescribing and stewardship in telemedicine

On Demand

Building your outpatient stewardship program: Leveraging your hospital/health system resources

On Demand

Commitment and Comparison: Sociobehavioral Interventions to Improve the Use of Antibiotics in the Outpatient Setting

On Demand

Interactive panel and Q&A

On Demand

Outpatient antibiotic use and the core elements of outpatient antibiotic stewardship: Updates from CDC

On Demand

Tracking and reporting of outpatient antibiotic use: Which metrics to use and how to measure them - Speaker 1

On Demand

Tracking and reporting of outpatient antibiotic use: Which metrics to use and how to measure them - Speaker 2

On Demand

Tracking and reporting of outpatient antibiotic use: Which metrics to use and how to measure them - Speaker 3

On Demand

PW09 - How to Use EBM/GRADE to Develop Guidelines

On Demand

PW10 - TB Workshop

On Demand

Beyond Isoniazid for Latent TB

On Demand

COVID Pandemonium: Lessons for TB control among Latinos

On Demand

Impact of COVID on TB Panel

On Demand

Impact of COVID-19 on Recent U.S. Tuberculosis Trends

On Demand

Novel TB vaccines 100 years after introduction of BCG

On Demand

Personal Reflections on COVID-19 and Tuberculosis

On Demand

Updated Impact of the COVID-19 Pandemic on Global Tuberculosis: A Modelling Analysis

On Demand

AE-01 - Gain inSIGHT into an Immunocompromised Patient's T Cell Immune Response featuring: CMV and SARS-CoV-2